Global Microbiome Drugs Market 2018 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Microbiome Drugs market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Microbiome Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microbiome Drugs development in United States, Europe and China.
    
    The key players covered in this study
        Pfizer
        Second Genome
        Seres Therapeutics
        MaaT Pharma
        Enterome Bioscience
        MicroBiome Therapeutics
        Ritter Pharmaceuticals
        Rebiotix
        OpenBiome
    
    Market segment by Type, the product can be split into
        Probiotics
        Prebiotics
        Small Molecules
        Biological Drugs
        Other
    
    Market segment by Application, split into
        Hospital Pharmacies
        Retail Pharmacies
        Online Pharmacies
        Other
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Microbiome Drugs status, future forecast, growth opportunity, key market and key players.
        To present the Microbiome Drugs development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Microbiome Drugs are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Microbiome Drugs Market Size Growth Rate by Type (2013-2025)
            1.4.2 Probiotics
            1.4.3 Prebiotics
            1.4.4 Small Molecules
            1.4.5 Biological Drugs
            1.4.6 Other
        1.5 Market by Application
            1.5.1 Global Microbiome Drugs Market Share by Application (2013-2025)
            1.5.2 Hospital Pharmacies
            1.5.3 Retail Pharmacies
            1.5.4 Online Pharmacies
            1.5.5 Other
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Microbiome Drugs Market Size
        2.2 Microbiome Drugs Growth Trends by Regions
            2.2.1 Microbiome Drugs Market Size by Regions (2013-2025)
            2.2.2 Microbiome Drugs Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Microbiome Drugs Market Size by Manufacturers
            3.1.1 Global Microbiome Drugs Revenue by Manufacturers (2013-2018)
            3.1.2 Global Microbiome Drugs Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
        3.2 Microbiome Drugs Key Players Head office and Area Served
        3.3 Key Players Microbiome Drugs Product/Solution/Service
        3.4 Date of Enter into Microbiome Drugs Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Microbiome Drugs Market Size by Type (2013-2018)
        4.2 Global Microbiome Drugs Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Microbiome Drugs Market Size (2013-2018)
        5.2 Microbiome Drugs Key Players in United States
        5.3 United States Microbiome Drugs Market Size by Type
        5.4 United States Microbiome Drugs Market Size by Application
    
    6 Europe
        6.1 Europe Microbiome Drugs Market Size (2013-2018)
        6.2 Microbiome Drugs Key Players in Europe
        6.3 Europe Microbiome Drugs Market Size by Type
        6.4 Europe Microbiome Drugs Market Size by Application
    
    7 China
        7.1 China Microbiome Drugs Market Size (2013-2018)
        7.2 Microbiome Drugs Key Players in China
        7.3 China Microbiome Drugs Market Size by Type
        7.4 China Microbiome Drugs Market Size by Application
    
    8 Japan
        8.1 Japan Microbiome Drugs Market Size (2013-2018)
        8.2 Microbiome Drugs Key Players in Japan
        8.3 Japan Microbiome Drugs Market Size by Type
        8.4 Japan Microbiome Drugs Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Microbiome Drugs Market Size (2013-2018)
        9.2 Microbiome Drugs Key Players in Southeast Asia
        9.3 Southeast Asia Microbiome Drugs Market Size by Type
        9.4 Southeast Asia Microbiome Drugs Market Size by Application
    
    10 India
        10.1 India Microbiome Drugs Market Size (2013-2018)
        10.2 Microbiome Drugs Key Players in India
        10.3 India Microbiome Drugs Market Size by Type
        10.4 India Microbiome Drugs Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Microbiome Drugs Market Size (2013-2018)
        11.2 Microbiome Drugs Key Players in Central & South America
        11.3 Central & South America Microbiome Drugs Market Size by Type
        11.4 Central & South America Microbiome Drugs Market Size by Application
    
    12 International Players Profiles
        12.1 Pfizer
            12.1.1 Pfizer Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Microbiome Drugs Introduction
            12.1.4 Pfizer Revenue in Microbiome Drugs Business (2013-2018)
            12.1.5 Pfizer Recent Development
        12.2 Second Genome
            12.2.1 Second Genome Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Microbiome Drugs Introduction
            12.2.4 Second Genome Revenue in Microbiome Drugs Business (2013-2018)
            12.2.5 Second Genome Recent Development
        12.3 Seres Therapeutics
            12.3.1 Seres Therapeutics Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Microbiome Drugs Introduction
            12.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)
            12.3.5 Seres Therapeutics Recent Development
        12.4 MaaT Pharma
            12.4.1 MaaT Pharma Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Microbiome Drugs Introduction
            12.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)
            12.4.5 MaaT Pharma Recent Development
        12.5 Enterome Bioscience
            12.5.1 Enterome Bioscience Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Microbiome Drugs Introduction
            12.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)
            12.5.5 Enterome Bioscience Recent Development
        12.6 MicroBiome Therapeutics
            12.6.1 MicroBiome Therapeutics Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Microbiome Drugs Introduction
            12.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)
            12.6.5 MicroBiome Therapeutics Recent Development
        12.7 Ritter Pharmaceuticals
            12.7.1 Ritter Pharmaceuticals Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Microbiome Drugs Introduction
            12.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)
            12.7.5 Ritter Pharmaceuticals Recent Development
        12.8 Rebiotix
            12.8.1 Rebiotix Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Microbiome Drugs Introduction
            12.8.4 Rebiotix Revenue in Microbiome Drugs Business (2013-2018)
            12.8.5 Rebiotix Recent Development
        12.9 OpenBiome
            12.9.1 OpenBiome Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Microbiome Drugs Introduction
            12.9.4 OpenBiome Revenue in Microbiome Drugs Business (2013-2018)
            12.9.5 OpenBiome Recent Development
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Microbiome Drugs Key Market Segments
        Table Key Players Microbiome Drugs Covered
        Table Global Microbiome Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Microbiome Drugs Market Size Market Share by Type 2013-2025
        Figure Probiotics Figures
        Table Key Players of Probiotics
        Figure Prebiotics Figures
        Table Key Players of Prebiotics
        Figure Small Molecules Figures
        Table Key Players of Small Molecules
        Figure Biological Drugs Figures
        Table Key Players of Biological Drugs
        Figure Other Figures
        Table Key Players of Other
        Table Global Microbiome Drugs Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospital Pharmacies Case Studies
        Figure Retail Pharmacies Case Studies
        Figure Online Pharmacies Case Studies
        Figure Other Case Studies
        Figure Microbiome Drugs Report Years Considered
        Table Global Microbiome Drugs Market Size 2013-2025 (Million US$)
        Figure Global Microbiome Drugs Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Microbiome Drugs Market Size by Regions 2013-2025 (Million US$)
        Table Global Microbiome Drugs Market Size by Regions 2013-2018 (Million US$)
        Table Global Microbiome Drugs Market Share by Regions 2013-2018
        Figure Global Microbiome Drugs Market Share by Regions 2013-2018
        Figure Global Microbiome Drugs Market Share by Regions 2018
        Table Market Top Trends
        Table Global Microbiome Drugs Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Microbiome Drugs Market Share by Manufacturers (2013-2018)
        Figure Global Microbiome Drugs Market Share by Manufacturers in 2018
        Table Global Microbiome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Microbiome Drugs Product/Solution/Service
        Table Date of Enter into Microbiome Drugs Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Global Microbiome Drugs Market Size Share by Type (2013-2018)
        Figure Global Microbiome Drugs Market Size Market Share by Type (2013-2018)
        Table Global Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Global Microbiome Drugs Market Size Share by Application (2013-2018)
        Figure Global Microbiome Drugs Market Size Market Share by Application (2013-2018)
        Figure Global Microbiome Drugs Revenue Market Share by Application in 2017
        Figure United States Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table United States Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table United States Key Players Microbiome Drugs Market Share (2017-2018)
        Table United States Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table United States Microbiome Drugs Market Share by Type (2013-2018)
        Table United States Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table United States Microbiome Drugs Market Share by Application (2013-2018)
        Figure Europe Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table Europe Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table Europe Key Players Microbiome Drugs Market Share (2017-2018)
        Table Europe Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Europe Microbiome Drugs Market Share by Type (2013-2018)
        Table Europe Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Europe Microbiome Drugs Market Share by Application (2013-2018)
        Figure China Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table China Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table China Key Players Microbiome Drugs Market Share (2017-2018)
        Table China Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table China Microbiome Drugs Market Share by Type (2013-2018)
        Table China Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table China Microbiome Drugs Market Share by Application (2013-2018)
        Figure Japan Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table Japan Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table Japan Key Players Microbiome Drugs Market Share (2017-2018)
        Table Japan Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Japan Microbiome Drugs Market Share by Type (2013-2018)
        Table Japan Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Japan Microbiome Drugs Market Share by Application (2013-2018)
        Figure Southeast Asia Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Microbiome Drugs Market Share (2017-2018)
        Table Southeast Asia Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Microbiome Drugs Market Share by Type (2013-2018)
        Table Southeast Asia Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Microbiome Drugs Market Share by Application (2013-2018)
        Figure India Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table India Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table India Key Players Microbiome Drugs Market Share (2017-2018)
        Table India Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table India Microbiome Drugs Market Share by Type (2013-2018)
        Table India Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table India Microbiome Drugs Market Share by Application (2013-2018)
        Figure Central & South America Microbiome Drugs Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Microbiome Drugs Market Share (2017-2018)
        Table Central & South America Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Microbiome Drugs Market Share by Type (2013-2018)
        Table Central & South America Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Microbiome Drugs Market Share by Application (2013-2018)
        Table Pfizer Company Details
        Table Pfizer Revenue in Microbiome Drugs Business (2013-2018) (Million US$)
        Figure Pfizer Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table Pfizer Recent Development
        Table Second Genome Company Details
        Table Second Genome Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure Second Genome Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table Second Genome Recent Development
        Table Seres Therapeutics Company Details
        Table Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table Seres Therapeutics Recent Development
        Table MaaT Pharma Company Details
        Table MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure MaaT Pharma Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table MaaT Pharma Recent Development
        Table Enterome Bioscience Company Details
        Table Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure Enterome Bioscience Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table Enterome Bioscience Recent Development
        Table MicroBiome Therapeutics Company Details
        Table MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure MicroBiome Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table MicroBiome Therapeutics Recent Development
        Table Ritter Pharmaceuticals Company Details
        Table Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table Ritter Pharmaceuticals Recent Development
        Table Rebiotix Company Details
        Table Rebiotix Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table Rebiotix Recent Development
        Table OpenBiome Company Details
        Table OpenBiome Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
        Figure OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
        Table OpenBiome Recent Development
        Table Global Microbiome Drugs Market Size by Regions (Million US$) 2018-2025
        Figure Global Microbiome Drugs Market Size Share by Regions (2018-2025)
        Figure Global Microbiome Drugs Market Size Share by Regions in 2025
        Figure United States Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure China Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure India Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
        Table Global Microbiome Drugs Market Size by Product (2018-2025) (Million US$)
        Figure Global Microbiome Drugs Market Size by Product (2018-2025)
        Figure Global Microbiome Drugs Market Size by Product in 2025
        Table Global Microbiome Drugs Market Size by Application (2018-2025) (Million US$)
        Figure Global Microbiome Drugs Market Size by Application (2018-2025)
        Figure Global Microbiome Drugs Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources